221 related articles for article (PubMed ID: 32932224)
61. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
[TBL] [Abstract][Full Text] [Related]
62. Establishment and characterization of a novel cell line, NCC-TGCT1-C1, derived from a patient with tenosynovial giant cell tumor.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Jan; 34(1):254-259. PubMed ID: 32886306
[TBL] [Abstract][Full Text] [Related]
63. A New Simple and Practical Clinical Classification for Tenosynovial Giant Cell Tumors of the Knee.
Zheng K; Yu XC; Hu YC; Xu M; Zhang JY
Orthop Surg; 2022 Feb; 14(2):290-297. PubMed ID: 34914180
[TBL] [Abstract][Full Text] [Related]
64. Risk factors for early osteoarthritis in tenosynovial giant cell tumour.
Machado V; San-Julián M
Rev Esp Cir Ortop Traumatol (Engl Ed); 2020; 64(3):199-205. PubMed ID: 31980414
[TBL] [Abstract][Full Text] [Related]
65. Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts.
Stacchiotti S; Dürr HR; Schaefer IM; Woertler K; Haas R; Trama A; Caraceni A; Bajpai J; Baldi GG; Bernthal N; Blay JY; Boye K; Broto JM; Chen WT; Dei Tos PA; Desai J; Emhofer S; Eriksson M; Gronchi A; Gelderblom H; Hardes J; Hartmann W; Healey J; Italiano A; Jones RL; Kawai A; Leithner A; Loong H; Mascard E; Morosi C; Otten N; Palmerini E; Patel SR; Reichardt P; Rubin B; Rutkowski P; Sangalli C; Schuster K; Seddon BM; Shkodra M; Staals EL; Tap W; van de Rijn M; van Langevelde K; Vanhoenacker FMM; Wagner A; Wiltink L; Stern S; Van de Sande VM; Bauer S
Cancer Treat Rev; 2023 Jan; 112():102491. PubMed ID: 36502615
[TBL] [Abstract][Full Text] [Related]
66. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
Tateishi U; Miyake M; Nagaoka T; Terauchi T; Kubota K; Kinoshita T; Daisaki H; Macapinlac HA
Radiology; 2012 Apr; 263(1):53-63. PubMed ID: 22438441
[TBL] [Abstract][Full Text] [Related]
67. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).
Tang S; Yin Y; Shen C; Chen J; Yin X; Zhang B; Yao Y; Yang J; Chen Z
World J Surg Oncol; 2017 Apr; 15(1):79. PubMed ID: 28399894
[TBL] [Abstract][Full Text] [Related]
68. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis.
Wang J; Yin Y; Shen C; Yin X; Cai Z; Pu L; Fu W; Wang Y; Zhang B
Medicine (Baltimore); 2020 Feb; 99(9):e19275. PubMed ID: 32118738
[TBL] [Abstract][Full Text] [Related]
69. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China.
Du CY; Zhou Y; Song C; Wang YP; Jie ZG; He YL; Liang XB; Cao H; Yan ZS; Shi YQ
Eur J Cancer; 2014 Jul; 50(10):1772-1778. PubMed ID: 24768330
[TBL] [Abstract][Full Text] [Related]
70. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
[TBL] [Abstract][Full Text] [Related]
71. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
72. Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases.
Stinauer MA; Diot Q; Westerly DC; Schefter TE; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e613-8. PubMed ID: 22494588
[TBL] [Abstract][Full Text] [Related]
73. Burden of Illness Associated with Tenosynovial Giant Cell Tumors.
Burton TM; Ye X; Parker ED; Bancroft T; Healey J
Clin Ther; 2018 Apr; 40(4):593-602.e1. PubMed ID: 29580718
[TBL] [Abstract][Full Text] [Related]
74. Magnetic resonance imaging features of intra-articular tenosynovial giant cell tumor in children.
Nguyen JC; Biko DM; Nguyen MK; Othman S; Weber KL; Ganley TJ; Arkader A
Pediatr Radiol; 2021 Mar; 51(3):441-449. PubMed ID: 33156428
[TBL] [Abstract][Full Text] [Related]
75. Arthroscopic resection of localized tenosynovial giant cell tumor in the deep infrapatellar bursa: a case report.
Dimnjaković D; Bojanić I
Croat Med J; 2023 Apr; 64(2):135-139. PubMed ID: 37131315
[TBL] [Abstract][Full Text] [Related]
76. Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers.
Mastboom MJL; Staals EL; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Palmerini E; Schaap GR; Jutte PC; Aston W; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; van de Sande MAJ;
J Bone Joint Surg Am; 2019 Jul; 101(14):1309-1318. PubMed ID: 31318811
[TBL] [Abstract][Full Text] [Related]
77. Unusual manifestations of diffuse-type tenosynovial giant cell tumor in two patients: importance of radiologic-pathologic correlation.
Dundar A; Young JR; Wenger DE; Inwards CY; Broski SM
Skeletal Radiol; 2020 Mar; 49(3):483-489. PubMed ID: 31656976
[TBL] [Abstract][Full Text] [Related]
78. Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis.
Thongchot S; Duangkaew S; Yotchai W; Maungsomboon S; Phimolsarnti R; Asavamongkolkul A; Thuwajit P; Thuwajit C; Chandhanayingyong C
Hum Cell; 2023 Jan; 36(1):456-467. PubMed ID: 36456782
[TBL] [Abstract][Full Text] [Related]
79. Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review.
Alsayadi YMMA; Chawla PA
Anticancer Agents Med Chem; 2021; 21(12):1510-1519. PubMed ID: 33143617
[TBL] [Abstract][Full Text] [Related]
80. Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in Denmark.
Ehrenstein V; Andersen SL; Qazi I; Sankar N; Pedersen AB; Sikorski R; Acquavella JF
J Rheumatol; 2017 Oct; 44(10):1476-1483. PubMed ID: 28765257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
